Caricamento...

SABCS 2016: systemic therapy for metastatic breast cancer

At the 2016 San Antonio Breast Cancer Symposium, several interesting phase II and phase III studies investigating systemic therapies for metastatic breast cancer were presented. The PrEGOC 0102 trial demonstrated that the combination of fulvestrant plus everolimus is safe and effective and could be...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Memo
Autori principali: Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Greil, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Vienna 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5493725/
https://ncbi.nlm.nih.gov/pubmed/28725277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-017-0326-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !